← Leaderboards
Brian Andrew Van Tine
Washington University
$2,165,920
Attributed
$2,165,920
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $382.2K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,165,920 · 2
By mechanism
R01$1,807,536 · 1
U54$358,384 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Timothy J Eberlein$71,591,509
- Li Ding$30,836,856
- Ramaswamy Govindan$14,816,161
- David G Mutch$5,912,807
- Mark A Watson$16,564,971
Others in their field
Other Emerging Leaders on “Programs”
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
- Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
ProgramsClinical TrialsResistanceMalignant NeoplasmsCombined Modality TherapyPathway InteractionsCell DivisionAmmoniaCell KillingCarbonArginineBiological MarkersBiomarker DevelopmentArginine DeiminaseCitrullineCorrelative StudyCancer CellBloodAntimetabolitesCellsAnabolismCell Cycle ArrestCell DeathBiopsy
Grant awards (8)
Pilot Projects and Trans-Network Activities Core$169,134
U54 · FY2025 · CA · contact PI
Pilot Projects and Trans-Network Activities Core$160,333
U54 · FY2024 · CA · contact PI
USING ARGININE METABOLIC THERAPIES FOR SARCOMA$353,321
R01 · FY2023 · CA · contact PI
Pilot Projects and Trans-Network Activities Core$28,917
U54 · FY2023 · CA · contact PI
USING ARGININE METABOLIC THERAPIES FOR SARCOMA$360,531
R01 · FY2022 · CA · contact PI
USING ARGININE METABOLIC THERAPIES FOR SARCOMA$363,301
R01 · FY2021 · CA · contact PI
USING ARGININE METABOLIC THERAPIES FOR SARCOMA$365,724
R01 · FY2020 · CA · contact PI
USING ARGININE METABOLIC THERAPIES FOR SARCOMA$364,659
R01 · FY2019 · CA · contact PI